FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 11/17/2011 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 11/17/2011 | M | 20,000 | A | $12.6 | 327,697 | D | |||
Common Stock | 11/17/2011 | S(1) | 1,400 | D | $72.7579(2) | 326,297 | D | |||
Common Stock | 11/17/2011 | S(1) | 6,400 | D | $73.7864(3) | 319,897 | D | |||
Common Stock | 11/17/2011 | S(1) | 1,200 | D | $74.9133(4) | 318,697 | D | |||
Common Stock | 11/17/2011 | S(1) | 4,900 | D | $75.9423(5) | 313,797 | D | |||
Common Stock | 11/17/2011 | S(1) | 1,100 | D | $76.6636(6) | 312,697 | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Non-Qualified Stock Option (right to buy) | $12.6 | 11/17/2011 | M | 20,000 | (7) | 01/28/2012 | Common Stock | 20,000 | $0 | 60,320 | D |
Explanation of Responses: |
1. The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/03/2011. |
2. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $72.27 to $73.21, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6 to this Form 4. |
3. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $73.41 to $74.3875, inclusive. |
4. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $74.41 to $75.37, inclusive. |
5. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $75.494 to $76.4525, inclusive. |
6. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $76.50 to $76.82, inclusive. |
7. Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (01/28/2003) of the date of grant. |
Remarks: |
Conan R. Deady, Attorney-in-Fact for Jonathan W. Ayers | 11/18/2011 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |